Annual EBITDA
-$390.12M$43.18M+9.97%
Summary
- Current Value
- As of today, GH annual EBITDA is -$390.12M, up +9.97% on
- Historical Performance
- GH annual EBITDA is down -8.48% over the past 3 years, and down -582.85% over the past 5 years
- All-Time High Comparison
- GH annual EBITDA is currently -889.60% below its historical high of -$39.42M set on
- 3-Year Low Comparison
- GH annual EBITDA is +36.56% above its 3-year low of -$614.91M reached on an earlier date
- Sector Comparison
- GH annual EBITDA is higher than 2.80% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$390.12M | +10.0% | -8.5% | -582.9% | -889.6% | |
| Quarterly EBITDA | -$89.59M | +16.1% | +33.3% | -28.2% | – | |
| TTM EBITDA | -$402.32M | +14.8% | +12.8% | -152.2% | – | |
| Price | $110.17 | +201.1% | +296.4% | -22.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $739.02M | +31.0% | +97.8% | +244.7% | +2826.9% | |
| Annual EPS | -$3.56 | +17.0% | +11.2% | -325.8% | -558.2% | |
| Annual EBIT | -$432.51M | +9.2% | -13.3% | -531.0% | -903.1% | |
| Annual Net Income | -$436.37M | +9.0% | -13.4% | -543.1% | -845.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$390.12M | at high | |
| 5Y | -$225.07M | N/A | -73.3% |
| All | -$39.42M | -889.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$614.91M | N/A | +36.6% |
| 5Y | -$614.91M | +36.6% | |
| All | -$614.91M | +36.6% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$390.12M | +10.0% | |
| -$433.31M | +29.5% | |
| -$614.91M | -71.0% | |
| -$359.62M | -59.8% | |
| -$225.07M | -294.0% |
| Year | Value | Change |
|---|---|---|
| -$57.13M | +24.7% | |
| -$75.84M | -0.7% | |
| -$75.31M | -91.0% | |
| -$39.42M | - |
FAQ
What is the current annual EBITDA of GH?
As of today, GH annual EBITDA is -$390.12M
What is 1-year change in GH annual EBITDA?
GH annual EBITDA is up +9.97% year-over-year
What is 3-year change in GH annual EBITDA?
GH annual EBITDA is down -8.48% over the past 3 years
How far is GH annual EBITDA from its all-time high?
GH annual EBITDA is currently -889.60% below its historical high of -$39.42M set on December 31, 2016
How does GH annual EBITDA rank versus sector peers?
GH annual EBITDA is higher than 2.80% of companies in Healthcare sector
When is GH next annual earnings release?
The next annual earnings release for GH is on
Quarterly EBITDA
-$89.59M$6.82M+7.08%
Summary
- Current Value
- As of today, GH quarterly EBITDA is -$89.59M, up +7.08% on
- Historical Performance
- GH quarterly EBITDA is up +16.06% year-over-year, and up +33.34% over the past 3 years
- All-Time High Comparison
- GH quarterly EBITDA is currently -639.31% below its historical high of -$12.12M set on
- 3-Year Low Comparison
- GH quarterly EBITDA is +51.91% above its 3-year low of -$186.31M reached on
- Sector Comparison
- GH quarterly EBITDA is higher than 3.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$89.59M | +7.1% | +16.1% | +33.3% | -28.2% | |
| Annual EBITDA | -$390.12M | – | +10.0% | -8.5% | -582.9% | |
| TTM EBITDA | -$402.32M | +4.1% | +14.8% | +12.8% | -152.2% | |
| Price | $110.17 | +68.8% | +201.1% | +296.4% | -22.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $265.20M | +14.3% | +38.5% | +125.9% | +255.6% | |
| Quarterly EPS | -$0.74 | +7.7% | +15.2% | +53.1% | +4.8% | |
| Quarterly EBIT | -$98.99M | +7.0% | +15.6% | +31.4% | -33.3% | |
| Quarterly Net Income | -$92.73M | +7.2% | +13.9% | +42.8% | -29.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$89.59M | at high | |
| 3Y | -$88.97M | -0.7% | |
| 5Y | -$86.56M | N/A | -3.5% |
| All | -$12.12M | -639.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$115.51M | N/A | +22.4% |
| 3Y | -$186.31M | +51.9% | |
| 5Y | -$186.31M | +51.9% | |
| All | -$186.31M | +51.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GH?
As of today, GH quarterly EBITDA is -$89.59M
What is GH quarterly EBITDA most recent change?
GH quarterly EBITDA was up +7.08% on September 30, 2025
What is 1-year change in GH quarterly EBITDA?
GH quarterly EBITDA is up +16.06% year-over-year
How far is GH quarterly EBITDA from its all-time high?
GH quarterly EBITDA is currently -639.31% below its historical high of -$12.12M set on March 31, 2018
How does GH quarterly EBITDA rank versus sector peers?
GH quarterly EBITDA is higher than 3.44% of companies in Healthcare sector
When is GH next earnings release?
The next earnings release for GH is on
TTM EBITDA
-$402.32M$17.14M+4.09%
Summary
- Current Value
- As of today, GH TTM EBITDA is -$402.32M, up +4.09% on
- Historical Performance
- GH TTM EBITDA is up +14.75% year-over-year, and up +12.80% over the past 3 years
- All-Time High Comparison
- GH TTM EBITDA is currently -1392.94% below its historical high of -$26.95M set on
- 3-Year Low Comparison
- GH TTM EBITDA is +22.62% above its 3-year low of -$519.91M reached on
- Sector Comparison
- GH TTM EBITDA is higher than 2.26% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$402.32M | +4.1% | +14.8% | +12.8% | -152.2% | |
| Annual EBITDA | -$390.12M | – | +10.0% | -8.5% | -582.9% | |
| Quarterly EBITDA | -$89.59M | +7.1% | +16.1% | +33.3% | -28.2% | |
| Price | $110.17 | +68.8% | +201.1% | +296.4% | -22.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $902.57M | +8.9% | +30.4% | +109.5% | +232.7% | |
| TTM EPS | -$3.21 | +4.0% | +24.2% | +45.9% | -68.1% | |
| TTM EBIT | -$442.41M | +4.0% | +14.1% | +10.3% | -145.7% | |
| TTM Net Income | -$398.79M | +3.6% | +22.2% | +32.1% | -127.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$401.13M | N/A | -0.3% |
| 3Y | -$401.13M | -0.3% | |
| 5Y | -$225.80M | N/A | -78.2% |
| All | -$26.95M | -1392.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$419.46M | +4.1% | |
| 3Y | -$519.91M | +22.6% | |
| 5Y | -$519.91M | +22.6% | |
| All | -$519.91M | +22.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GH?
As of today, GH TTM EBITDA is -$402.32M
What is GH TTM EBITDA most recent change?
GH TTM EBITDA was up +4.09% on September 30, 2025
What is 1-year change in GH TTM EBITDA?
GH TTM EBITDA is up +14.75% year-over-year
How far is GH TTM EBITDA from its all-time high?
GH TTM EBITDA is currently -1392.94% below its historical high of -$26.95M set on September 30, 2017
How does GH TTM EBITDA rank versus sector peers?
GH TTM EBITDA is higher than 2.26% of companies in Healthcare sector
When is GH next earnings release?
The next earnings release for GH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- GH Official Website guardanthealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1576280/000157628025000277/0001576280-25-000277-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576280/000157628025000044/0001576280-25-000044-index.htm
- GH Profile on Yahoo Finance finance.yahoo.com/quote/GH
- GH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gh